|
ES2539045T3
(es)
*
|
2009-01-19 |
2015-06-25 |
Innate Pharma |
Anticuerpos anti-KIR3D
|
|
MX369148B
(es)
|
2012-09-19 |
2019-10-30 |
Innate Pharma |
Agentes de unión kir3dl2.
|
|
ES2878749T3
(es)
|
2013-02-20 |
2021-11-19 |
Innate Pharma |
Un compuesto que se une específicamente a KIR3DL2 para el uso en el tratamiento de linfoma de células T periférico
|
|
KR102345173B1
(ko)
|
2014-03-14 |
2021-12-29 |
이나뜨 파르마 에스.에이. |
증가된 안정성을 가진 인간화 항체
|
|
JP6822849B2
(ja)
|
2014-06-27 |
2021-01-27 |
イナート・ファルマ・ソシエテ・アノニムＩｎｎａｔｅ Ｐｈａｒｍａ Ｐｈａｒｍａ Ｓ．Ａ． |
多重特異的ＮＫｐ４６結合タンパク質
|
|
WO2015197598A2
(en)
|
2014-06-27 |
2015-12-30 |
Innate Pharma |
Multispecific antigen binding proteins
|
|
WO2016030488A1
(en)
*
|
2014-08-27 |
2016-03-03 |
Innate Pharma |
Treatment of celiac disease
|
|
EP4019552A1
(en)
|
2015-06-10 |
2022-06-29 |
National Research Council of Canada |
Carbonic anhydrase ix-specific antibodies and uses thereof
|
|
AU2016284871B2
(en)
|
2015-06-23 |
2022-09-29 |
Innate Pharma |
Multispecific NK engager proteins
|
|
DK3313876T3
(da)
|
2015-06-23 |
2025-04-22 |
Innate Pharma |
Multispecifikke antigenbindende proteiner
|
|
WO2017156423A2
(en)
*
|
2016-03-11 |
2017-09-14 |
Integrated Biotherapeutics, Inc. |
Broadly protective antibody cocktails for treatment of filovirus hemorrhagic fever
|
|
US10858431B2
(en)
*
|
2016-06-30 |
2020-12-08 |
Trellis Bioscience, Llc |
Monoclonal antibodies targeting killer immunoglobulin-like receptor (KIR) family signaling
|
|
EP3529277A1
(en)
*
|
2016-10-21 |
2019-08-28 |
Innate Pharma |
Treatment with anti-kir3dl2 agents
|
|
US20190322767A1
(en)
|
2016-12-23 |
2019-10-24 |
Innate Pharma |
Heterodimeric antigen binding proteins
|
|
CA3052291A1
(en)
*
|
2017-02-09 |
2018-08-16 |
Memorial Sloan Kettering Cancer Center |
Anti-kir3dl1 antibodies
|
|
CN111032083B
(zh)
*
|
2017-05-24 |
2024-01-12 |
财团法人生物技术开发中心 |
抗globo h的人源化抗体及其在癌症治疗中的用途
|
|
US10947316B2
(en)
*
|
2017-06-15 |
2021-03-16 |
Development Center For Biotechnology |
Antibody-drug conjugates containing anti-Globo H antibodies and uses thereof
|
|
WO2018237364A1
(en)
*
|
2017-06-22 |
2018-12-27 |
Development Center For Biotechnology |
Asymmetric heterodimeric fc-scfv fusion anti-globo h and anti-cd3 bispecifc antibody and uses thereof in caner therapy
|
|
EP3713959A1
(en)
|
2017-11-21 |
2020-09-30 |
Innate Pharma |
Multispecific antigen binding proteins
|
|
WO2019156223A1
(ja)
*
|
2018-02-09 |
2019-08-15 |
国立大学法人大阪大学 |
チクングニアウイルスに対する抗体またはその抗原結合断片、およびその用途
|
|
WO2020035345A1
(en)
|
2018-08-14 |
2020-02-20 |
Innate Pharma |
Treatment of colorectal cancer by a combination of an anti-mica antibody and an anti-nkg2a antibody
|
|
JP7611834B2
(ja)
|
2019-01-22 |
2025-01-10 |
イナート・ファルマ・ソシエテ・アノニム |
Ｔ細胞リンパ腫の処置
|
|
IL291897A
(en)
|
2019-10-04 |
2022-06-01 |
Albert Einstein College Medicine |
Kir3dl3 inhibitory receptor of the immune system and its uses
|
|
CN110950960B
(zh)
*
|
2019-11-26 |
2021-05-14 |
中国农业大学 |
基于高通量测序和杂合杂交瘤技术的小分子化合物抗体的制备方法
|
|
CN113817052A
(zh)
*
|
2020-06-19 |
2021-12-21 |
南京金斯瑞生物科技有限公司 |
抗SARS-CoV-2核衣壳蛋白单克隆抗体及其制备方法和用途
|
|
EP4288455A1
(en)
|
2021-02-03 |
2023-12-13 |
Mozart Therapeutics, Inc. |
Binding agents and methods of using the same
|
|
WO2022200525A1
(en)
|
2021-03-26 |
2022-09-29 |
Innate Pharma |
Multispecific proteins comprising an nkp46-binding site, a cancer antgienge binding site fused to a cytokine for nk cell engaging
|
|
KR20230165913A
(ko)
|
2021-04-05 |
2023-12-05 |
이나뜨 파르마 에스.에이. |
면역조직화학 방법 및 kir3dl2-특이적 시약
|
|
WO2022258678A1
(en)
|
2021-06-09 |
2022-12-15 |
Innate Pharma |
Multispecific proteins binding to nkp30, a cytokine receptor, a tumour antigen and cd16a
|
|
BR112023025331A2
(pt)
|
2021-06-09 |
2024-02-27 |
Innate Pharma |
Proteína multiespecífica, composição farmacêutica, célula recombinante, ácido nucleico ou conjunto de ácidos nucleicos, uso de uma proteína ou composição, métodos ou uso
|
|
WO2022258691A1
(en)
|
2021-06-09 |
2022-12-15 |
Innate Pharma |
Multispecific proteins binding to nkg2d, a cytokine receptor, a tumour antigen and cd16a
|
|
KR20240019786A
(ko)
|
2021-06-09 |
2024-02-14 |
이나뜨 파르마 에스.에이. |
Cd20, nkp46, cd16에 결합하고 il-2에 접합된 다중특이적 항체
|
|
CN113248609B
(zh)
*
|
2021-07-14 |
2021-09-10 |
深圳市盛波尔生命科学技术有限责任公司 |
针对再生胰岛衍生蛋白1α的抗体组合以及包含其的检测试剂盒
|
|
US20250121090A1
(en)
*
|
2021-07-30 |
2025-04-17 |
R.P. Scherer Technologies, Llc |
Antibody-Drug Conjugates and Methods of Use Thereof
|
|
WO2023076876A1
(en)
|
2021-10-26 |
2023-05-04 |
Mozart Therapeutics, Inc. |
Modulation of immune responses to viral vectors
|
|
IL319568A
(en)
|
2022-09-15 |
2025-05-01 |
Avidicure Ip B V |
Multispecific antigen-binding proteins for NK cell stimulation and their uses
|
|
WO2024251884A1
(en)
|
2023-06-09 |
2024-12-12 |
Innate Pharma |
Nk cell engager proteins comprising anti-cd20 and ant-nkp46 antibody, linked to il-2 in treatment of r/r b-nhl
|
|
CN117801108B
(zh)
*
|
2023-12-06 |
2024-06-07 |
无锡傲锐东源生物科技有限公司 |
抗人mdm2蛋白单克隆抗体及其杂交瘤细胞株和应用
|
|
WO2025191133A1
(en)
|
2024-03-15 |
2025-09-18 |
Avidicure Ip B.V. |
Il-21 muteins, fusion proteins comprising the same and uses thereof
|
|
WO2025191139A1
(en)
|
2024-03-15 |
2025-09-18 |
Avidicure Ip B.V. |
Conjugates of her2-specific antigen binding proteins and cytokines
|
|
WO2025191136A1
(en)
|
2024-03-15 |
2025-09-18 |
Avidicure Ip B.V. |
Muteins of 4-1bb ligand extracellular domain, fusion proteins comprising the same and uses thereof
|
|
WO2025245386A1
(en)
*
|
2024-05-23 |
2025-11-27 |
La Jolla Institute For Immunology |
Kir3dl2 as an anti-cancer target
|